Showing results (1821-1830 of 2,938) with videos related to
Sort By:
Pageof 294
Cancer Investigation|January 1, 1995
Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinomaM Turrill, D V Spicer, A S Kelley, et al.Cancer Investigation|January 1, 1995
Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomasP V Elizalde, F K Guerra, M Gravano, et al.Cancer Investigation|January 1, 1995
Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: a report of two casesA W Tolcher, R M Giusti, J A O'Shaughnessy, et al.Cancer Investigation|July 31, 2007
Colorectal cancer: intrinsic characteristics modulate cancer energy expenditure and the risk of cachexiaPaula Ravasco, Isabel Monteiro-Grillo, Maria CamiloCancer Investigation|July 31, 2007
Soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) is decreased in lung cancer patients showing progression: a pilot studyA Yilmaztepe, E Ulukaya, B Zik, et al.Cancer Investigation|July 9, 2008
Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stressClaudia A Sánchez, Emma Rodríguez, Elvira Varela, et al.Cancer Investigation|July 9, 2008
Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cellsY M Yang, J W ChangCancer Investigation|July 9, 2008
Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancerDuygu Derin, Yesim Eralp, Yasemin Ozluk, et al.Cancer Investigation|June 17, 2006
Comparison of changes in erythrocyte and platelet fatty acid composition and protein oxidation in advanced non-small cell lung cancerJavier de Castro, Angel Hernández-Hernández, Marina C Rodríguez, et al.Cancer Investigation|June 17, 2006
A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancerJulian R Molina, Daniel Nikcevich, Shauna Hillman, et al.Pageof 294